GLP1s and AUD, CVD risk, lipid lowering targets, and status on vaccine for gonorrhea
This week's topics include GLP1s and AUD, impact of CVD risk calculation, meeting lipid lowering targets, and no luck with a vaccine for gonorrhea.
CVD risk factors, cognitive decline, insulin price, and factors in IBD
This week's topics include visceral fat and CVD risk factors, delirium and cognitive decline and hospitalization, caps on insulin price, and factors involved with IBD.
Nonprofit hospital work, GLP-1 use, weight loss drugs, and transcranial stimulation
This week's topics include outcomes after consultant work in nonprofit hospitals, use of GLP-1s in AUD, a model for predicting benefit from weight loss medicines, and transcranial stimulation for ASD.
Sleep in adolescents, GLP1s, predicting Alzheimer's, and cancer screenings
This week's topics include sleep in adolescents, GLP1s in different people, predicting Alzheimer's onset, and screening for colorectal cancer and potential harms.